Cargando…
Disease site number was not prognostic in a low-risk Hodgkin lymphoma combined modality trial: revisiting PHC HOD90
Autores principales: | Feraco, Angela M., Zhou, Yiwang, Zheng, Ying, Marks, Lianna J., Friedmann, Alison, Weinstein, Howard J., Link, Michael P., Flerlage, Jamie E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society of Hematology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10637876/ https://www.ncbi.nlm.nih.gov/pubmed/37647596 http://dx.doi.org/10.1182/bloodadvances.2023010944 |
Ejemplares similares
-
Hod mice and the mouse set conjecture
por: Sargsyan, Grigor
Publicado: (2015) -
Critical policy passed during historic HoD
por: Bzowyckyj, Andrew
Publicado: (2020) -
PhcA and PhcR Regulate Ralsolamycin Biosynthesis Oppositely in Ralstonia solanacearum
por: Li, Peng, et al.
Publicado: (2022) -
T-HOD: a literature-based candidate gene database for hypertension, obesity and diabetes
por: Dai, Hong-Jie, et al.
Publicado: (2013) -
PHC: the future of oncology drug development
por: Yao, Yihong
Publicado: (2012)